Daidzein attenuates inflammation and exhibits antifibrotic effect against Bleomycin-induced pulmonary fibrosis in Wistar rats

Biomedicine and Preventive Nutrition

Volumn 1, Issue 4, 2011, Pages 236-244

  Soumyakrishnan, Syamala ^a   Sudhandiran, Ganapasam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Bleomycin; Collagen; Daidzein; Pulmonary fibrosis; TNF

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BLEOMYCIN; CATALASE; COLLAGEN; DAIDZEIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROXYPROLINE; MYELOPEROXIDASE; RETINOL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME ACTIVITY; INFLAMMATION; LIPID PEROXIDATION; LUNG FIBROSIS; MALE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT; TISSUE STRUCTURE; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION;

RATTUS NORVEGICUS;

EID: 83855164029     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.09.005     Document Type: Article

References (68)

1. Wang H., Yamaya M., Okinaga S., Jia Y., Kamanaka M., Takahashi H., et al. Bilirubin ameliorates Bleomycin-Induced Pulmonary Fibrosis in rats. Am J Respir Crit Care Med 2002, 165:406-411.
2. Murakami S., Nagaya N., Itoh T., Fujii T., Iwase T., Hamada K., et al. C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2004, 287:1172-1177.
3. Gross T.J., Hunninghake G.W. Idiopathic pulmonary fibrosis. N Engl J Med 2001, 345:517-525.
4. Ruiz V., Rosa M.O., Berumen J., Ramirez R., Uhal B., Becerril C., et al. Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2003, 285:1026-1036.
5. Mercer P.F., Deng X., Chambers R.C. Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury. Ann N Y Acad Sci 2007, 1096:86-88.
6. Gurujeyalakshmi G., Wang Y., Giri S.N. Taurine and Niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kB in mice. J Pharmacol Exp Ther 2000, 293:82-90.
7. Gharaee-Kermani M., Nozaki Y., Hatano K., Phan S.H. Lung Interleukin-4 gene expression in a murine model of Bleomycin-induced pulmonary fibrosis. Cytokine 2001, 15:138-147.
8. Wilson M.S., Wynn T.A. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2009, 2:103-121.
9. Chen F., Gong F., Zhang L., Wang H., Qi X., Wu X., et al. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. Eur J Pharmacol 2006, 536:287-295.
10. Grande N.R., Peão M.N.D., de Sá C.M., Águas A.P. Lung fibrosis induced by bleomycin: structural changes and overview of recent advances. Scanning Microsc 1998, 12:487-494.
11. Yen F.L., Wu T.H., Liao C.W., Lin C.C. A kampo medicine, Yin-Chiao-san, prevents Bleomycin-induced pulmonary injury in rats. Phytother Res 2007, 21:251-258.
12. Ertekin A., Deger Y., Mert H., Mert N., Yur F., Dede S., et al. Investigation of the effects of α-Tocopherol on the levels of Fe, Cu, Zn, Mn, and carbonic anhydrase in rats with Bleomycin-Induced Pulmonary Fibrosis. Biol Trace Elem Res 2007, 116:289-300.
13. Endo M., Oyadomari S., Terasaki Y., Takeya M., Suga M., Mori M., et al. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol 2003, 285:313-321.
14. Ozyurt H., Sogut S., Yi{dotless}ldi{dotless}ri{dotless}m Z., Kart L., Iraz M., Armutcu F., et al. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta 2004, 339:65-75.
15. Venkatesan N., Punithavathi V., Chandrakasan G. Curcumin protects bleomycin-induced lung injury in rats. Life Sci 1997, 61:51-58.
16. Fichtner F., Koslowski R., Augstein A., Hempel U., Rohlecke C., Kasper M. Bleomycin induces IL-8 and ICAM-1 expression in microvascular pulmonary endothelial cells. Exp Toxic Pathol 2004, 55:497-503.
17. Ishii H., Takada H. Bleomycin Induces E-selectin expression in cultured umbilical vein endothelial cells by increasing its mRNA levels through activation of NF-κB/Rel. Toxicol Appl Pharmacol 2002, 184:88-97.
18. Lamartiniere C.A., Wang J., Smith-Johnson M., Eltoum I. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci 2002, 65:228-238.
19. Mi Y.L., Zhang C.Q., Zeng W.D., Liu J.X., Liu H.Y. The isoflavonoid daidzein attenuates the oxidative damage induced by polychlorinated biphenyls on cultured chicken testicular cells. Poult Sci 2007, 86:2008-2012.
20. Gardner C.D., Oelrich B., Liu J., Feldman D., Franke A.A., Brooks J.D. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate 2009, 69:719-726.
21. Chacko B.K., Chandler R.T., D'Alessandro T.L., Mundhekar A., Khoo N.K., Botting N., et al. Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma. J Nutr 2007, 137:351-356.
22. Mizushige T., Mizushige K., Miyatake A., Kishida T., Ebihira K. Inhibitory effects of soy Isoflavones on cardiovascular collagen accumulation in rats. J Nutr Sci Vitaminol 2007, 53:48-52.
23. Schreihofer D.A., Redmond L. Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience 2010, 158:602-609.
24. Setchell K.D., Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: Evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003, 78:593-609.
25. Mann G.E., Bonacasa B., Ishii T., Siow R.C. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary Isoflavones. Curr Opin Pharmacol 2009, 9:139-145.
26. Vedavanam K., Srijayanta S., O' Reilly J., Raman A., Wiseman H. Antioxidant action and potential ant diabetic properties of an isoflavanoid- containing soyabean phytochemical extract (SPE). Phytother Res 1999, 13:601-608.
27. Sriram N., Kalayarasan S., Sudhandiran G. Enhancement of Antioxidant Defense System by Epigallocatechin-3-gallate during Bleomycin Induced Experimental Pulmonary Fibrosis. Biol Pharm Bull 2008, 31:1306-1311.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951, 193:265-275.
29. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972, 247:3170-3175.
30. Takahara S., Hamilton H.B., Neel J.V., Kobara T.Y., Ogura Y., Nishimura E.T. Hypocatalasemia: a new genetic carrier state. J Clin Invest 1960, 39:610-619.
31. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
32. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
33. Omaye S.T., Tumbull J.D., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 1979, 62:3-11.
34. Desai I.D. Vitamin E analysis method for animal tissues. Methods Enzymol 1984, 105:138-143.
35. Bayfield R.K., Cole E.R. Colorimetric estimation of vitamin A with trichloroacetic acid. Methods Enzymol 1980, 67:189-195.
36. Ohkawa H., Ohishi N., Yagi K. Assay of lipoperoxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
37. Wei H., Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993, 14:1195-1201.
38. Neuman R.E., Logan M.A. The determination of collagen and elastin in tissues. J Biol Chem 1950, 186:549-556.
39. Pick R., Jalil J.E., Janicki J.S., Weber K.T. The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol 1989, 134:365-371.
40. Chen X.L., Li W.B., Zhou A.M., Ai J., Huang S.S. Role of endogenous peroxynitrite in pulmonary injury and fibrosis induced by bleomycin A5 in rats. Acta Pharmacologica Sin 2003, 24:697-702.
41. Venkatesan N., Roughley P.J., Ludwigi M.S. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-β1 and interferon-γ Am J Physiol Lung Cell Mol Physiol 2002, 283:806-814.
42. Wang G., Qi B., Zheng H., Chen Z., Wei X., Ma L., et al. (Z)-5-(4-Methoxybenzylidene)thiazolidine-2,4-dione, a novel readily available and orally active glitazone, attenuates the Bleomycin-Induced Pulmonary Fibrosis in vivo. Biol Pharm Bull 2011, 34:219-225.
43. Ortis L.A., Champion H.C., Lasky J.A., Gambelli F., Gozal E., Hoyle G.W., et al. Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kB and AP-1. Am J Physiol Lung Cell Mol Physiol 2002, 282:1209-1221.
44. Razzaque S.M., Taguchi T. Pulmonary fibrosis: cellular and molecular events. Pathol Int 2003, 53:133-145.
45. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214:199-210.
46. Woodman O.L., Boujaoude M. Chronic treatment of male rats with daidzein and 17b-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation. Br J Pharmacol 2004, 141:322-328.
47. Mishra P., Kar A., Kale R.K. Prevention of chemically induced mammary tumorigenesis by daidzein in pre-pubertal rats: the role of peroxidative damage and antioxidative enzymes. Mol Cell Biochem 2009, 325:149-157.
48. Serrano-Mollar A., Closa D., Prats N., Blesa S., Martinez-Losa M., Cortijo J., et al. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 2003, 138:1037-1048.
49. Kinnula V.L., Fattman C.L., Tan R.J., Oury T.D. Oxidative stress in pulmonary fibrosis. Possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005, 172:417-422.
50. Boyac H.M., Maral H., Turan G., Basyigit I̧., Dillioglugil M.O., Yi{dotless}ldi{dotless}z F., Tugay M., et al. Effects of erdosteine on bleomycin-induced lung fibrosis in rats. Mol Cell Biochem 2006, 281:129-137.
51. Hasnain B.I., Mooradain A.D. Recent trials of antioxidant therapy: what should we be telling our patients?. Cleve Clin J Med 2004, 71:327-334.
52. MacKay D., Miller A.L. Nutritional support for wound healing. Altern Med Rev 2003, 8:359-377.
53. Bolt M.W., Racz W.J., Brien J.F., Massey T.E. Effects of vitamin E on cytotoxicity of amiodarone and N-desethylamiodarone in isolated hamster lung cells. Toxicology 2001, 166:109-118.
54. Card J.W., Racz W.J., Brien J.F., Massey T.E. Attenuation of amiodarone induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-beta1 gene expression but not prevention of mitochondrial dysfunction. J Pharmacol Exp Ther 2003, 304:277-283.
55. Samhan-Arias A.K., Tyurina Y.Y., Kagan V.E. Lipid antioxidants: free radical scavenging versus regulation of enzymatic lipid peroxidation. J Clin Biochem Nutr 2011, 8:91-95.
56. Li W., Wu J.X., Tu Y.Y. Synergistic effects of tea polyphenols and ascorbic acid on human lung adenocarcinoma SPC-A-1 cells. J Zhejiang Univ Sci B 2010, 11:458-464.
57. Jeong Y.J., Kim J.H., Kang J.S., Lee W.L., Hwang Y. Mega-dose vitamin C attenuated lung inflammation in mouse asthma model. Anat Cell Biol 2010, 43:294-302.
58. Santhosh S., Sini T.K., Anandan R., Mathew P.T. Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. Eur J Pharmacol 2007, 572:69-73.
59. Jaganjac M. Possible involvement of granulocyte oxidative burst in Nrf2 signaling in cancer. Indian J Med Res 2010, 131:609-616.
60. Di Paola R., Talero E., Galuppo M., Mazzon E., Bramanti P., Motilva V., et al. Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis. Respir Res 2011, 41:1-12.
61. Knaapen A.M., Schins R.P., Borm P.J., van Schooten F.J. Nitrite enhances neutrophil-induced DNA strand breakage in pulmonary epithelial cells by inhibition of myeloperoxidase. Carcinogenesis 2005, 26:1642-1648.
62. Schindhelm P.K., van der Zwan L.P., Teerlink T., Scheffer P.G., Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification?. Clin Chem 2009, 55:1462-1470.
63. Gazdhar A., Fachinger P., van Leer C., Pierog J., Gugger M., Friis R., et al. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007, 292:529-536.
64. El-Medany A., Hagar H.H., Moursi M., At Muhammed R., El-Rakhawy F.I., El-Medany G. Attenuation of bleomycin-induced lung fibrosis in rats by mesna. Eur Pharmacol 2005, 509:61-70.
65. Arafa H.M.M., Abdel-Wahab M.H., El-Shafeey M.F., Badary O.A., Hamada F.M.A. Anti-fibrotic effect of meloxicam in a murine lung fibrosis model. Eur J Pharmacol 2007, 564:181-189.
66. Zhao L., Wang X., Chang O., Xu J., Huang Y., Guo O., et al. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. Eur J Pharmacol 2010, 627:304-312.
67. Kalayarasan S., Sriram N., Sudhandiran G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-κB, TNF-α and IL-1β. Life Sciences 2008, 82:1142-1153.
68. Burkhardt A., Höltje W.J., Gebbers J.O. Vascular lesions following perfusion with bleomycin. Electron-microscopic observations. Virchows Arch A Pathol Anat Histol 1976, 372:227-236.